Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finel

Showing results (181-190 of 248) with videos related to

Pageof 25
Sort By:
Analytica Chimica Acta|March 14, 2021
A fluorescence-based microplate assay for high-throughput screening and evaluation of human UGT inhibitorsQi-Hang Zhou, Xia Lv, Zhen-Hao Tian, et al.
International Journal of Biological Macromolecules|December 31, 2018
Inhibition of UGT1A1 by natural and synthetic flavonoidsXin-Yu Liu, Xia Lv, Ping Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 12, 2014
A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivativesAleksandra K Greer, Centdrika R Dates, Athena Starlard-Davenport, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2018
A Novel Pathogenic <i>UGT1A1</i> Variant in a Sudanese Child with Type 1 Crigler-Najjar SyndromeWalaa Elfar, Erkka Järvinen, Weizhen Ji, et al.
Biochimica Et Biophysica Acta|May 2, 2012
Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemiaPaula S Montenegro-Miranda, Nina Sneitz, D Rudi de Waart, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 2007
Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferasesAgnieszka Zielinska, Cheryl F Lichti, Stacie Bratton, et al.
Cytotherapy|March 8, 2021
Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registryMohamed-Amine Bekadja, Ariane Boumendil, Didier Blaise, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 1, 2007
The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysisYan Xiong, Anne-Sisko Patana, Michael J Miley, et al.
Leukemia|September 20, 2014
Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working PartyA Tanase, N Schmitz, H Stein, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2017
Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions<sup> </sup>Helinä Kahma, Anne M Filppula, Mikko Neuvonen, et al.
Pageof 25

Showing results (181-190 of 248) with videos related to

Sort By:
Pageof 25
Analytica Chimica Acta|March 14, 2021
A fluorescence-based microplate assay for high-throughput screening and evaluation of human UGT inhibitorsQi-Hang Zhou, Xia Lv, Zhen-Hao Tian, et al.
International Journal of Biological Macromolecules|December 31, 2018
Inhibition of UGT1A1 by natural and synthetic flavonoidsXin-Yu Liu, Xia Lv, Ping Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 12, 2014
A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivativesAleksandra K Greer, Centdrika R Dates, Athena Starlard-Davenport, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2018
A Novel Pathogenic <i>UGT1A1</i> Variant in a Sudanese Child with Type 1 Crigler-Najjar SyndromeWalaa Elfar, Erkka Järvinen, Weizhen Ji, et al.
Biochimica Et Biophysica Acta|May 2, 2012
Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemiaPaula S Montenegro-Miranda, Nina Sneitz, D Rudi de Waart, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 2007
Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferasesAgnieszka Zielinska, Cheryl F Lichti, Stacie Bratton, et al.
Cytotherapy|March 8, 2021
Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registryMohamed-Amine Bekadja, Ariane Boumendil, Didier Blaise, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 1, 2007
The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysisYan Xiong, Anne-Sisko Patana, Michael J Miley, et al.
Leukemia|September 20, 2014
Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working PartyA Tanase, N Schmitz, H Stein, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2017
Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions<sup> </sup>Helinä Kahma, Anne M Filppula, Mikko Neuvonen, et al.
Pageof 25